Truvestments Capital LLC Buys New Stake in Clorox Co (CLX)

Truvestments Capital LLC bought a new position in shares of Clorox Co (NYSE:CLX) during the first quarter, Holdings Channel reports. The institutional investor bought 255 shares of the company’s stock, valued at approximately $41,000.

Several other hedge funds and other institutional investors have also made changes to their positions in CLX. JPMorgan Chase & Co. increased its holdings in Clorox by 5.2% in the third quarter. JPMorgan Chase & Co. now owns 1,019,248 shares of the company’s stock valued at $153,305,000 after buying an additional 50,360 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in Clorox by 15.1% in the third quarter. Bank of New York Mellon Corp now owns 1,664,803 shares of the company’s stock valued at $250,403,000 after buying an additional 218,364 shares during the last quarter. Allianz Asset Management GmbH increased its holdings in Clorox by 16.1% in the third quarter. Allianz Asset Management GmbH now owns 23,996 shares of the company’s stock valued at $3,609,000 after buying an additional 3,319 shares during the last quarter. Pacer Advisors Inc. increased its holdings in Clorox by 18.7% in the third quarter. Pacer Advisors Inc. now owns 7,037 shares of the company’s stock valued at $1,058,000 after buying an additional 1,108 shares during the last quarter. Finally, Man Group plc increased its holdings in Clorox by 123.9% in the third quarter. Man Group plc now owns 14,578 shares of the company’s stock valued at $2,193,000 after buying an additional 8,066 shares during the last quarter. 76.90% of the stock is currently owned by institutional investors and hedge funds.

CLX has been the subject of several recent research reports. Zacks Investment Research lowered Clorox from a “hold” rating to a “sell” rating in a report on Tuesday, April 9th. Barclays reaffirmed a “hold” rating and set a $142.00 target price on shares of Clorox in a report on Wednesday, February 6th. Credit Suisse Group initiated coverage on Clorox in a report on Wednesday, March 6th. They set an “outperform” rating and a $172.00 target price for the company. Wells Fargo & Co reaffirmed a “hold” rating and set a $157.00 target price on shares of Clorox in a report on Thursday, February 21st. Finally, BMO Capital Markets set a $175.00 target price on Clorox and gave the company a “buy” rating in a report on Tuesday, February 5th. Six equities research analysts have rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $151.21.

Shares of NYSE CLX opened at $152.34 on Wednesday. The company has a debt-to-equity ratio of 3.08, a current ratio of 1.15 and a quick ratio of 0.66. The company has a market cap of $19.79 billion, a PE ratio of 24.34, a price-to-earnings-growth ratio of 3.86 and a beta of 0.32. Clorox Co has a 12-month low of $113.57 and a 12-month high of $167.70.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 4th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.32 by $0.08. The business had revenue of $1.47 billion during the quarter, compared to the consensus estimate of $1.47 billion. Clorox had a return on equity of 105.97% and a net margin of 12.65%. The business’s revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.77 earnings per share. On average, analysts predict that Clorox Co will post 6.31 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a $0.96 dividend. The ex-dividend date is Tuesday, April 23rd. This represents a $3.84 dividend on an annualized basis and a yield of 2.52%. Clorox’s dividend payout ratio (DPR) is 61.34%.

In other Clorox news, SVP Andrew J. Mowery sold 5,340 shares of the company’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $156.44, for a total value of $835,389.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Matthew T. Laszlo sold 10,585 shares of the company’s stock in a transaction that occurred on Wednesday, February 6th. The stock was sold at an average price of $153.89, for a total value of $1,628,925.65. Following the completion of the sale, the senior vice president now owns 17,994 shares of the company’s stock, valued at $2,769,096.66. The disclosure for this sale can be found here. Corporate insiders own 1.40% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Truvestments Capital LLC Buys New Stake in Clorox Co (CLX)” was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://sportsperspectives.com/2019/04/17/truvestments-capital-llc-buys-new-stake-in-clorox-co-clx.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: Diversification

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.